US4675187A
(en)
|
1983-05-16 |
1987-06-23 |
Bristol-Myers Company |
BBM-1675, a new antibiotic complex
|
US4554162A
(en)
|
1984-05-04 |
1985-11-19 |
Warner-Lambert Company |
CL-1724 Antibiotic compounds, their production and use
|
US4539203A
(en)
|
1984-11-13 |
1985-09-03 |
Warner-Lambert Company |
CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use
|
US4970198A
(en)
|
1985-10-17 |
1990-11-13 |
American Cyanamid Company |
Antitumor antibiotics (LL-E33288 complex)
|
US6018030A
(en)
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
US5079233A
(en)
|
1987-01-30 |
1992-01-07 |
American Cyanamid Company |
N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
|
US5037651A
(en)
|
1987-01-30 |
1991-08-06 |
American Cyanamid Company |
Dihydro derivatives of LL-E33288 antibiotics
|
US4837206A
(en)
|
1987-04-29 |
1989-06-06 |
Bristol-Myers Company |
Esperamicin derivatives
|
LU87693A1
(fr)
|
1990-03-07 |
1991-10-08 |
Wurth Paul Sa |
Sonde de prise d'echantillons gazeux et de mesures thermiques dans un four a cuve
|
US5264586A
(en)
|
1991-07-17 |
1993-11-23 |
The Scripps Research Institute |
Analogs of calicheamicin gamma1I, method of making and using the same
|
US5589458A
(en)
|
1992-11-13 |
1996-12-31 |
Thomas Jefferson University |
Compounds that inhibit T cell proliferation and methods for using the same
|
US5817303A
(en)
|
1995-05-05 |
1998-10-06 |
Protein Polymer Technologies, Inc. |
Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
|
US5712127A
(en)
|
1996-04-29 |
1998-01-27 |
Genescape Inc. |
Subtractive amplification
|
US6617434B1
(en)
|
1996-05-31 |
2003-09-09 |
North Shore Long Island Jewish Research Institute |
Identificiaton of differentially methylated and mutated nucleic acids
|
US5871917A
(en)
|
1996-05-31 |
1999-02-16 |
North Shore University Hospital Research Corp. |
Identification of differentially methylated and mutated nucleic acids
|
US7411051B2
(en)
|
1997-03-07 |
2008-08-12 |
Human Genome Sciences, Inc. |
Antibodies to HDPPA04 polypeptide
|
US6057098A
(en)
|
1997-04-04 |
2000-05-02 |
Biosite Diagnostics, Inc. |
Polyvalent display libraries
|
DE122010000049I1
(de)
|
1997-04-15 |
2011-05-05 |
Daiichi Sankyo Co Ltd |
Neues protein und verfahren zu dessen herstellung
|
FR2767337B1
(fr)
|
1997-08-14 |
2002-07-05 |
Pasteur Institut |
Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
|
CA2321817C
(en)
|
1998-03-04 |
2011-02-01 |
Genencor International, Inc. |
Modified forms of pullulanase
|
US6472367B1
(en)
|
1998-05-05 |
2002-10-29 |
Adherex Technologies, Inc. |
Compounds and methods for modulating OB-cadherin mediated cell adhesion
|
US7060433B1
(en)
|
1999-11-12 |
2006-06-13 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening using diphtheria toxin constructs
|
US7090976B2
(en)
|
1999-11-10 |
2006-08-15 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising Renilla GFP
|
US7534579B2
(en)
|
1998-06-30 |
2009-05-19 |
Millennium Pharmaceuticals, Inc. |
14273 receptor, a novel G-protein coupled receptor
|
US7662409B2
(en)
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US7488590B2
(en)
|
1998-10-23 |
2009-02-10 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
US20030104526A1
(en)
|
1999-03-24 |
2003-06-05 |
Qiang Liu |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
US6942981B1
(en)
|
1999-05-14 |
2005-09-13 |
Arbor Vita Corporation |
Method of determining interactions with PDZ-domain polypeptides
|
US20090175821A1
(en)
|
1999-05-17 |
2009-07-09 |
Bridon Dominique P |
Modified therapeutic peptides with extended half-lives in vivo
|
JP2003509465A
(ja)
|
1999-07-19 |
2003-03-11 |
エピミューン, インコーポレイテッド |
ペプチドおよび核酸組成物を使用する、c型肝炎ウイルスに対する細胞性免疫応答の誘導
|
AU2001237973B2
(en)
|
2000-01-26 |
2006-09-07 |
Agensys, Inc. |
84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
|
US7585839B2
(en)
|
2000-02-23 |
2009-09-08 |
Zealand Pharma A/S |
Medical uses of intercellular communication facilitating compounds
|
US7378248B2
(en)
|
2000-03-06 |
2008-05-27 |
Rigel Pharmaceuticals, Inc. |
In vivo production of cyclic peptides for inhibiting protein-protein interaction
|
US7358330B2
(en)
|
2001-03-29 |
2008-04-15 |
Biotempt B.V. |
Immunoregulatory compositions
|
EP1300418A1
(en)
|
2001-10-04 |
2003-04-09 |
Erasmus Universiteit Rotterdam |
Gene regulation by oligopeptides
|
TWI318983B
(en)
|
2000-05-02 |
2010-01-01 |
Uab Research Foundation |
An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
|
AU2001294520A1
(en)
|
2000-08-21 |
2002-03-04 |
Clonex Development, Inc. |
Methods and compositions for increasing protein yield from a cell culture
|
US7358353B2
(en)
|
2000-08-22 |
2008-04-15 |
Agensys, Inc. |
Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
|
JP2004515751A
(ja)
|
2000-09-08 |
2004-05-27 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
インビトロターゲティングのための方法および組成物
|
AU2002233994A1
(en)
|
2000-11-08 |
2002-05-21 |
Incyte Genomics, Inc. |
Secreted proteins
|
US7608704B2
(en)
|
2000-11-08 |
2009-10-27 |
Incyte Corporation |
Secreted proteins
|
AU2002222747A1
(en)
|
2000-12-12 |
2002-06-24 |
Angiolab, Inc. |
Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
|
AU2002246708A1
(en)
|
2000-12-15 |
2002-08-12 |
Agensys, Inc. |
Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US20040076992A1
(en)
|
2001-02-15 |
2004-04-22 |
Yusuke Nakamura |
Novel cell adhesion molecule specific to activated leukocyte
|
EP1379265A4
(en)
|
2001-03-28 |
2005-09-14 |
Helix Biomedix Inc |
SHORT BIOACTIVE PEPTIDES AND METHODS OF USE
|
EP2280030A3
(en)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
US6967021B2
(en)
|
2001-04-27 |
2005-11-22 |
Trustees Of Tufts College |
Use of Galectin-3 to promote the re-epithelialization of wounds
|
AU2002257440A1
(en)
|
2001-05-07 |
2002-11-18 |
National Research Council Of Canada |
Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
|
EP1406680A4
(en)
|
2001-06-15 |
2007-01-10 |
Johns Hopkins Singapore Pte Lt |
BIOFUNCTIONAL FIBERS
|
KR20040023630A
(ko)
|
2001-06-26 |
2004-03-18 |
아브게닉스, 인크. |
Opgl에 결합하는 항체
|
EP1485707B1
(en)
|
2001-07-16 |
2009-01-14 |
caprotec bioanalytics GmbH |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US7033991B2
(en)
|
2001-07-16 |
2006-04-25 |
Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College |
Inhibiting furin with polybasic peptides
|
US20090075377A1
(en)
|
2001-08-03 |
2009-03-19 |
Arbor Vita Corporation |
Molecular interactions in cells
|
US7402664B2
(en)
|
2002-09-03 |
2008-07-22 |
Genencor International, Inc. |
Nucleic acids and expression vectors comprising carotenoid binding peptides
|
JP4120778B2
(ja)
|
2001-09-26 |
2008-07-16 |
国立大学法人 奈良先端科学技術大学院大学 |
骨代謝異常疾患マーカー及びその利用
|
AU2002364699A1
(en)
|
2001-11-13 |
2003-06-17 |
Incyte Genomics, Inc. |
Receptors and membrane-associated proteins
|
JP2003210166A
(ja)
|
2001-11-16 |
2003-07-29 |
Sanyo Chem Ind Ltd |
変温動物由来細胞の細胞接着基材
|
US20080242618A1
(en)
|
2001-12-21 |
2008-10-02 |
Khan Nisar A |
Stratification
|
US7786084B2
(en)
|
2001-12-21 |
2010-08-31 |
Biotempt B.V. |
Treatment of burns
|
US20080318871A1
(en)
|
2001-12-21 |
2008-12-25 |
Khan Nisar A |
Treatment of neurological disorders
|
US7560433B2
(en)
|
2001-12-21 |
2009-07-14 |
Biotempt B.V. |
Treatment of multiple sclerosis (MS)
|
US7501391B2
(en)
|
2001-12-21 |
2009-03-10 |
Biotempt B.V. |
Treatment of transplant survival
|
US20080242837A1
(en)
|
2001-12-21 |
2008-10-02 |
Khan Nisar A |
Peptide compositions
|
US20080194489A1
(en)
|
2001-12-21 |
2008-08-14 |
Khan Nisar A |
Treatment of iatrogenic disease
|
WO2003057725A2
(en)
|
2002-01-09 |
2003-07-17 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
US7514407B2
(en)
|
2002-03-04 |
2009-04-07 |
Nymox Corporation |
Spheron component peptides and pharmaceutical compositions
|
US8298606B2
(en)
|
2002-03-08 |
2012-10-30 |
The Regents Of The University Of California |
Methods and compositions for stabilizing the myocardium
|
KR20030076448A
(ko)
|
2002-03-21 |
2003-09-26 |
주식회사 코메드 |
항-rank 단클론 항체 및 이를 함유한 약학 조성물
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
US7718776B2
(en)
|
2002-04-05 |
2010-05-18 |
Amgen Inc. |
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
|
US20040102608A1
(en)
|
2002-05-13 |
2004-05-27 |
Cornell Research Foundation, Inc. |
Multiblock copolymers having improved mechanical properties
|
WO2003096990A2
(en)
|
2002-05-17 |
2003-11-27 |
Montana State University |
Protein cages for the delivery of medical imaging and therapy
|
DK1513934T3
(da)
|
2002-06-06 |
2011-05-02 |
Oncotherapy Science Inc |
Gener og polypeptider relateret til humane coloncancersygdomme
|
ATE357255T1
(de)
|
2002-06-28 |
2007-04-15 |
Vlaams Interuniv Inst Biotech |
Plazenta-wachstumsfaktor als target für die behandlung von osteoporose
|
AU2003250102B2
(en)
|
2002-07-24 |
2009-09-17 |
Innogenetics N.V. |
Fragments of beta-amyloid as targets for vaccination against alzheimer disease
|
WO2004033482A2
(en)
|
2002-10-08 |
2004-04-22 |
Genencor International, Inc. |
Phenolic binding peptides
|
WO2004041845A2
(en)
|
2002-11-01 |
2004-05-21 |
Trustees Of Tufts College |
Templated native silk smectic gels
|
NZ572892A
(en)
|
2002-12-03 |
2010-03-26 |
Univ North Carolina State |
Prion protein ligands with the sequence YVHEA
|
JP2004189848A
(ja)
|
2002-12-10 |
2004-07-08 |
Giken:Kk |
炭化処理方法および炭化処理システム
|
EP2259068B1
(en)
|
2003-01-16 |
2013-08-14 |
caprotec bioanalytics GmbH |
Capture compounds and methods for analyzing the proteome
|
JP3906924B2
(ja)
|
2003-02-28 |
2007-04-18 |
独立行政法人農業生物資源研究所 |
絹タンパクから細胞生育ペプチドの抽出と利用
|
CN102021147B
(zh)
|
2003-03-24 |
2016-08-03 |
港大科桥有限公司 |
引起严重急性呼吸道综合征(sars)的新型人病毒及其应用
|
WO2004085650A1
(en)
|
2003-03-24 |
2004-10-07 |
The University Of Hong Kong |
A high-troughput diagnostic assay for the human virus causing severe acute respiratory syndrome (sars)
|
US7517529B2
(en)
|
2003-04-08 |
2009-04-14 |
Biotempt B.V. |
Treatment of type I diabetes
|
EP1613796B1
(en)
|
2003-04-10 |
2017-03-22 |
Tufts University |
Concentrated aqueous silk fibroin solution and use thereof
|
WO2004101790A1
(en)
|
2003-05-14 |
2004-11-25 |
Domantis Limited |
A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
|
JP3915983B2
(ja)
|
2003-05-27 |
2007-05-16 |
ゼライス株式会社 |
プロテアーゼ、このプロテアーゼをコードするdna、プロテアーゼの製造方法
|
EP1633380A4
(en)
|
2003-06-19 |
2010-08-11 |
Yeda Res & Dev |
ANTIMICROBIAL AND ANTICANCER LIPOPEPTIDES
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
FR2860237B1
(fr)
|
2003-09-30 |
2006-03-10 |
Centre Nat Rech Scient |
Polypeptide d'interaction comprenant un motif heptapeptidique et un domaine de penetration cellulaire
|
US20050118625A1
(en)
|
2003-10-02 |
2005-06-02 |
Mounts William M. |
Nucleic acid arrays for detecting gene expression associated with human osteoarthritis and human proteases
|
US20090226374A1
(en)
|
2003-10-27 |
2009-09-10 |
Health Aide, Inc. |
Anaphylatoxins for detecting clinical conditions
|
US20050153333A1
(en)
|
2003-12-02 |
2005-07-14 |
Sooknanan Roy R. |
Selective terminal tagging of nucleic acids
|
AT412785B
(de)
|
2003-12-04 |
2005-07-25 |
Kungl Andreas J Dr |
Gag-bindungsproteine
|
EP1544215A1
(en)
|
2003-12-17 |
2005-06-22 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Human anti-idiotypic antibody fragments that mimic HER-2/neu
|
US20090227505A1
(en)
|
2004-01-07 |
2009-09-10 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
EP1756272A2
(en)
|
2004-01-09 |
2007-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
|
WO2005072392A2
(en)
|
2004-01-28 |
2005-08-11 |
John Hopkins University |
Methods for making and using molecular switches involving circular permutation
|
TWI359026B
(en)
|
2004-02-12 |
2012-03-01 |
Sankyo Co |
Pharmaceutical composition for the osteoclast rela
|
EP3653641A1
(en)
|
2004-02-19 |
2020-05-20 |
Genentech, Inc. |
Cdr-repaired antibodies
|
BRPI0507822A
(pt)
|
2004-03-01 |
2007-07-10 |
Peptera Pharmaceuticals Ltd |
método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição autoimune ou infecciosa, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição do sangue, método e composição farmacêutica para modular a formação de células do sangue, método e composição farmacêutica para intensificar a mobilização periférico da célula tronco, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição metabólica, método e composição farmacêutica para a prevenção ou o tratamento das condições associadas com doses mieloablativas de quimioradioterapia suportadas pelo transplante autólogo de medula óssea ou de células tronco do sangue periférico (asct) ou pelo transplante alogenéico de medula óssea (bmt), método e composição farmacêutica para aumentar o efeito de um fator estimulante de células do sangue, método e composição farmacêutica para intensificar a colonização de células tronco do sangue doadas em um receptor mieloablatado, método e composição farmacêutica para a prevenção ou o tratamento de uma doença ou uma condição bacteriana, composição farmacêutica para o tratamento ou a prevenção de uma indicação selecionada do grupo que consiste em doença ou condição autoimune, doença viral, infecção viral, doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, hiperlipidemia, hipercolesterolemia, glucosuria, hiperglicemia, diabetes, aids, hiv-1, distúrbios de células t auxiliares, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, distúrbios do sistema imunológico resultantes da terapia de quimioterapia ou de radiação, distúrbios do sistema imunológico humano resultantes do tratamento das doenças de deficiência imunológica e infecções bacterianas, composição farmacêutica para o tratamento ou a prevenção de um indicação selecionada do grupo que consiste em doença hematológica, deficiências hematológicas, trombocitopenia, pancitopenia, granulopenia, deficiências de células dendrìticas, deficiências de macrofagos, distúrbios de células tronco hematopoiéticas incluindo distúrbios com plaquetas, linfócitos, células do plasma e neutrófilos, condições pré-leucêmicas, condições leucêmicas, sìndrome mielodisplástiacas, malignidades não mielóides, anemia plástica e insuficiência da medula óssea, peptìdeo purificado, peptìdeo quimérico purificado, peptìdeo quimérico, composição farmacêutica, composição farmacêutica para a prevenção ou o tratamento de uma condição associada com um agente infeccioso de sars, método de processamento a baixa temperatura de hidrolisato proteolìtico de caseìna e hidrolisato de proteìna de caseìna
|
TW200539855A
(en)
|
2004-03-15 |
2005-12-16 |
Wyeth Corp |
Calicheamicin conjugates
|
WO2005098043A2
(en)
|
2004-03-30 |
2005-10-20 |
The President And Fellows Of Harvard College |
Ligand-dependent protein splicing
|
JP2008506359A
(ja)
|
2004-04-08 |
2008-03-06 |
サンガモ バイオサイエンシズ インコーポレイテッド |
ジンクフィンガータンパク質による神経因性疼痛の処置
|
US7189697B2
(en)
|
2004-04-13 |
2007-03-13 |
Trustees Of Tufts College |
Compositions and uses of a galectin for treatment of dry eye syndrome
|
WO2005109158A2
(en)
|
2004-05-05 |
2005-11-17 |
Massachusetts Institute Of Technology |
Methods and systems for generating peptides
|
WO2006010057A2
(en)
|
2004-07-08 |
2006-01-26 |
Amgen Inc. |
Therapeutic peptides
|
EP1781328A4
(en)
|
2004-07-10 |
2009-06-03 |
Alexion Pharma Inc |
METHOD FOR DETECTING SPECIFIC ANTIBODIES TO CANCER CELLS AND ANTIBODIES SOUND
|
AT413946B
(de)
|
2004-07-13 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff gegen die alzheimer-krankheit
|
JP2008508320A
(ja)
|
2004-07-29 |
2008-03-21 |
カイロン コーポレイション |
Streptococcusagalactiaeのようなグラム陽性細菌に対する免疫原性組成物
|
CA2575622A1
(en)
|
2004-08-06 |
2006-02-09 |
Sopherion Therapeutics, Inc. |
Anti-angiogenic peptides and methods of use thereof
|
JP2006068378A
(ja)
|
2004-09-03 |
2006-03-16 |
Terumo Corp |
血管内留置物
|
US7265092B2
(en)
|
2004-09-30 |
2007-09-04 |
Kai Pharmaceuticals, Inc. |
Pharmaceutical formulation
|
CA2583843C
(en)
|
2004-10-13 |
2010-09-21 |
Crucell Holland B.V. |
Improved adenoviral vectors and uses thereof
|
CA2583399A1
(en)
|
2004-10-14 |
2006-04-27 |
Sopherion Therapeutics, Inc. |
Anti-angiogenic peptides and methods of use thereof
|
DK2586456T3
(en)
|
2004-10-29 |
2016-03-21 |
Ratiopharm Gmbh |
Conversion and glycopegylation of fibroblast growth factor (FGF)
|
EP1824976A4
(en)
|
2004-11-12 |
2008-07-09 |
Univ British Columbia |
ANTIMICROBIAL PEPTIDES
|
US20090221505A1
(en)
|
2004-11-16 |
2009-09-03 |
Mikhail Kolonin |
Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display
|
WO2006062776A2
(en)
|
2004-11-29 |
2006-06-15 |
The Regents Of The University Of California |
Hydroxyapatite-binding peptides for bone growth and inhibition
|
WO2006063462A1
(en)
|
2004-12-13 |
2006-06-22 |
Alethia Biotherapeutics Inc. |
Polynucleotides and polypeptide sequences involved in the process of bone remodeling
|
US20060160157A1
(en)
|
2005-01-19 |
2006-07-20 |
Zuckerman Mathew M |
Method, compositions and classification for tumor diagnostics and treatment
|
AU2006210724A1
(en)
|
2005-02-03 |
2006-08-10 |
Antitope Limited |
Human antibodies and proteins
|
CN101155825B
(zh)
|
2005-02-09 |
2014-11-26 |
赫里克斯生物医疗公司 |
抗微生物六肽
|
US8551774B2
(en)
|
2005-03-17 |
2013-10-08 |
National Research Council Of Canada |
Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression
|
US9162005B2
(en)
|
2005-04-25 |
2015-10-20 |
Arch Biosurgery, Inc. |
Compositions for prevention of adhesions and other barrier applications
|
JP2008539209A
(ja)
|
2005-04-26 |
2008-11-13 |
カリヨン−シーティーティー リミテッド |
診断及び治療剤
|
AU2006247188A1
(en)
|
2005-05-18 |
2006-11-23 |
Children's Hospital & Research Center At Oakland |
Methods and compositions for immunizing against chlamydia infection
|
US8227573B2
(en)
|
2005-05-20 |
2012-07-24 |
University Of Kentucky Research Foundation |
Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in plants
|
US7528232B2
(en)
|
2005-05-20 |
2009-05-05 |
The University Of Kentucky Research Foundation |
Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in crop plants
|
WO2007004869A2
(en)
|
2005-07-05 |
2007-01-11 |
Biotempt B.V. |
Treatment of tumors
|
JP4604184B2
(ja)
|
2005-07-12 |
2010-12-22 |
独立行政法人産業技術総合研究所 |
新規糖鎖認識蛋白質及びその遺伝子
|
WO2007019062A2
(en)
|
2005-08-11 |
2007-02-15 |
The Scripps Research Institute |
Zinc finger binding domains for cnn
|
WO2008024105A2
(en)
|
2005-08-22 |
2008-02-28 |
Genencor International, Inc. |
Nanocomposites of repeat sequence proteins and phyllosilicate clays and their preparation
|
WO2007027954A2
(en)
|
2005-08-30 |
2007-03-08 |
Children's Hospital & Research Center At Oakland |
Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof
|
JP2009508937A
(ja)
|
2005-09-22 |
2009-03-05 |
イエダ リサーチ アンド デベロップメント カンパニー リミテッド |
T細胞免疫を調節するためのジアステレオマーペプチド
|
JP2009509510A
(ja)
|
2005-09-26 |
2009-03-12 |
メダレックス インコーポレーティッド |
Cd70に対するヒトモノクローナル抗体
|
US20090099031A1
(en)
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
US7846445B2
(en)
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
JP5389442B2
(ja)
|
2005-09-29 |
2014-01-15 |
メディミューン,エルエルシー |
膜Ig特異的抗体を同定する方法および免疫グロブリンを生成する前駆体細胞を標的化するための使用
|
PL1934252T3
(pl)
|
2005-10-13 |
2015-10-30 |
Biocon Ltd |
Sposób wytwarzania koniugatów insuliny
|
US7575876B2
(en)
|
2005-10-27 |
2009-08-18 |
The University Of Washington |
Biomarkers for neurodegenerative disorders
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
WO2007055116A1
(ja)
|
2005-11-08 |
2007-05-18 |
Tohoku University |
質量分析計を使った膜タンパク質の定量方法
|
US8252338B2
(en)
|
2005-11-10 |
2012-08-28 |
The Regents Of The University Of California |
Synthetic LDL as targeted drug delivery vehicle
|
JP2009520463A
(ja)
|
2005-11-28 |
2009-05-28 |
ザ スクリプス リサーチ インスティテュート |
Tnnのための亜鉛フィンガー結合ドメイン
|
GB0524313D0
(en)
|
2005-11-29 |
2006-01-04 |
Imp College Innovations Ltd |
Particles
|
EP1866329B1
(en)
|
2005-12-16 |
2010-05-26 |
National Cancer Center |
Peptides for inhibiting transglutaminase
|
CA2822302A1
(en)
|
2006-02-13 |
2007-08-23 |
Alethia Biotherapeutics Inc. |
Methods of impairing osteoclast differentiation
|
US8168181B2
(en)
|
2006-02-13 |
2012-05-01 |
Alethia Biotherapeutics, Inc. |
Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
|
DK1986611T3
(da)
|
2006-02-23 |
2013-07-29 |
Danisco Us Inc |
Proteinpolymernanopartikler med repeat-sekvens, der eventuelt indeholder aktive stoffer, og fremstilling heraf
|
JP4831370B2
(ja)
|
2006-02-28 |
2011-12-07 |
独立行政法人科学技術振興機構 |
グルカン量を低減させることなくリグニン量およびセルロース量を低減させた植物体およびその生産方法、並びにこれらの利用
|
US7501557B1
(en)
|
2006-02-28 |
2009-03-10 |
University Of Kentucky Research Foundation |
Method utilizing the tobacco phylloplanin promoter for expression of nucleic acids as gene products directed to aerial surfaces of plants
|
AU2007222991A1
(en)
|
2006-03-09 |
2007-09-13 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods based on peptide binding profiling
|
US8148111B2
(en)
|
2006-03-17 |
2012-04-03 |
Sanyo Chemical Industries, Ltd. |
Cell culture carrier comprising poly(meth)acrylic (salt) particle and artificial polypeptide
|
JP5885378B2
(ja)
|
2006-03-22 |
2016-03-22 |
ザ スクリプス リサーチ インスティテュート |
グリコペプチドの調製法
|
JP2009532027A
(ja)
*
|
2006-03-28 |
2009-09-10 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
抗igf−1r抗体およびその使用
|
US9283260B2
(en)
|
2006-04-21 |
2016-03-15 |
Amgen Inc. |
Lyophilized therapeutic peptibody formulations
|
CA2652247C
(en)
|
2006-05-08 |
2015-11-17 |
Adaerata, Limited Partnership |
Chimeric pcsk9 proteins, cells comprising same, and assays using same
|
FR2900826B1
(fr)
|
2006-05-12 |
2008-08-15 |
Soc Extraction Principes Actif |
Utilisation de peptides en tant que principes actifs amincissants.
|
US20080069801A1
(en)
|
2006-06-13 |
2008-03-20 |
Lee Randall J |
Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications
|
CN101484462A
(zh)
|
2006-07-05 |
2009-07-15 |
斯克利普斯研究院 |
通过定向进化产生催化优化的嵌合锌指重组酶
|
JP2010507069A
(ja)
|
2006-07-08 |
2010-03-04 |
ユニバーシティー オブ ケンタッキー リサーチ ファンデーション |
肺癌診断アッセイ
|
WO2008021290A2
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
CL2007002502A1
(es)
|
2006-08-31 |
2008-05-30 |
Hoffmann La Roche |
Variantes del factor de crecimiento similar a insulina-1 humano (igf-1) pegilados en lisina; metodo de produccion; proteina de fusion que la comprende; y su uso para tratar la enfermedad de alzheimer.
|
JP2008094822A
(ja)
|
2006-09-15 |
2008-04-24 |
Univ Of Tokyo |
セルロース結合性ペプチドおよびその製造方法
|
WO2008055225A2
(en)
|
2006-10-31 |
2008-05-08 |
Musc Foundation For Research Development |
Systems and methods for in vivo measurement of interstitial biological activity, processes and/or compositions
|
AU2007322252A1
(en)
|
2006-11-01 |
2008-05-29 |
George Mason Intellectual Properties, Inc. |
Biomarkers for neurological conditions
|
ITTO20060852A1
(it)
|
2006-11-30 |
2008-06-01 |
Univ Degli Studi Torino |
Peptidi metastasi-specifici e loro applicazioni diagnostiche e terapeutiche
|
EP3248985B1
(en)
|
2007-01-19 |
2019-10-23 |
Kai Pharmaceuticals, Inc. |
Modifications of peptide compositions to increase stability and delivery efficiency
|
US9175422B2
(en)
|
2007-01-22 |
2015-11-03 |
The United States Of America As Represented By The Secretary Of The Army |
Polymer-micelle complex as an aid to electrospinning
|
AU2008211854C1
(en)
|
2007-01-29 |
2014-01-23 |
Procell Therapeutics Inc. |
Novel macromolecule transduction domains and methods for identification and uses thereof
|
CL2008000493A1
(es)
|
2007-02-16 |
2008-06-27 |
Genentech Inc |
Polipeptido que se une especificamente a un dominio pdz de la proteina htra1; polinucleotido que lo codifica; metodo de produccion; anticuerpo que se une a el; y su uso para tratar patologias relacionadas con la proteina htra1.
|
US9415084B2
(en)
|
2007-03-14 |
2016-08-16 |
Arch Biosurgery, Inc. |
Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
|
US20080299601A1
(en)
|
2007-03-15 |
2008-12-04 |
Invitrogen Corporation |
Adhering Surfaces
|
EP2578684B1
(en)
|
2007-03-19 |
2016-02-24 |
National Research Council Of Canada |
Antagonists of ligands and uses thereof
|
WO2008116468A2
(en)
|
2007-03-26 |
2008-10-02 |
Dako Denmark A/S |
Mhc peptide complexes and uses thereof in infectious diseases
|
JP2008263955A
(ja)
|
2007-03-29 |
2008-11-06 |
Sanyo Chem Ind Ltd |
無血清培地
|
US20080306001A1
(en)
|
2007-04-04 |
2008-12-11 |
Anzelika Liik |
Transcriptional modulation of extracellular matrix (ecm) of dermal fibroblasts
|
US20090142839A1
(en)
|
2007-05-04 |
2009-06-04 |
Shiloh Laboratories, Inc. |
Inducing Premature Senescence to Stabilize Stem Cell Feeder Layer Cells
|
US8097581B2
(en)
|
2007-05-10 |
2012-01-17 |
Grant Industries Inc. |
Anti-wrinkle cosmetic composition
|
US20100093554A1
(en)
|
2007-06-01 |
2010-04-15 |
Keting Chu |
Methods for identifying biomarkers, autoantibody signatures, and stratifying subject groups using peptide arrays
|
EP2009023A1
(en)
|
2007-06-04 |
2008-12-31 |
Rentschler Beteiligungs GmbH |
Novel peptides and their use for the treatment of edema
|
EP2155810A4
(en)
|
2007-06-13 |
2013-07-03 |
Fmc Corp |
ALGINATE-COATED, POLYSAC-CHARIDE-CONTAINING FOAM COMPOSITE, MANUFACTURING METHOD AND USES THEREOF
|
US20090017460A1
(en)
|
2007-06-15 |
2009-01-15 |
Wyeth |
Differential expression profiling analysis of cell culture phenotypes and uses thereof
|
US20100016215A1
(en)
|
2007-06-29 |
2010-01-21 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
WO2009005793A2
(en)
|
2007-06-29 |
2009-01-08 |
Avi Biopharma, Inc. |
Tissue specific peptide conjugates and methods
|
CN103212085A
(zh)
|
2007-07-12 |
2013-07-24 |
普罗森那技术公司 |
用于使化合物靶向多种选定器官或组织的分子
|
RS52305B
(en)
|
2007-07-16 |
2012-12-31 |
Genentech Inc. |
ANTI-CD79B ANTIBODIES AND IMMUNOCONCULATES AND METHODS OF USE
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
WO2009020101A1
(ja)
|
2007-08-06 |
2009-02-12 |
University Of Tsukuba |
花の形態が改変された植物体の生産方法
|
WO2009023125A1
(en)
|
2007-08-14 |
2009-02-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Neuronostatin and its uses
|
US8933197B2
(en)
|
2007-08-15 |
2015-01-13 |
Amunix Operating Inc. |
Compositions comprising modified biologically active polypeptides
|
EP2192906A4
(en)
|
2007-08-28 |
2014-10-29 |
Fmc Corp |
DELAYED SELF-GELING ALGINATE SYSTEMS AND USES THEREOF
|
KR100887266B1
(ko)
|
2007-09-04 |
2009-03-06 |
주식회사 프로셀제약 |
세포투과성 p18 재조합 단백질, 이를 코딩하는폴리뉴클레오티드 및 이를 유효성분으로 함유하는 항암조성물
|
JP5295242B2
(ja)
|
2007-09-04 |
2013-09-18 |
プロセル セラピューティックス インコーポレーティッド |
細胞透過性Nm23組換えタンパク質、これをコードするポリヌクレオチド及びこれを有効成分として含有する癌転移抑制用組成物
|
JP5000439B2
(ja)
|
2007-09-19 |
2012-08-15 |
三洋化成工業株式会社 |
細胞培養用担体
|
CN101969987A
(zh)
|
2007-09-20 |
2011-02-09 |
J·大卫格莱斯顿学会 |
长散布核元件多肽组合物及其使用方法
|
EP2197908A2
(en)
|
2007-09-27 |
2010-06-23 |
Dako Denmark A/S |
Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
|
NZ583397A
(en)
|
2007-10-11 |
2012-03-30 |
Daiichi Sankyo Co Ltd |
ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15
|
GB0720156D0
(en)
|
2007-10-15 |
2007-11-28 |
Univ Nottingham Trent |
Breast cancer associated antigen
|
CN101855235B
(zh)
|
2007-10-29 |
2013-04-24 |
赫里克斯生物医疗公司 |
保护性皮肤护理四肽
|
EP2538221A3
(en)
|
2007-11-05 |
2013-04-24 |
Nordic Bioscience A/S |
Biochemical markers for CVD risk assessment
|
US7923253B2
(en)
|
2007-11-05 |
2011-04-12 |
Battelle Memorial Institute |
Method for identifying type I diabetes mellitus in humans
|
US20110021442A1
(en)
|
2007-11-06 |
2011-01-27 |
Daewoong Jo |
Cell preamble runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same
|
US20110262508A1
(en)
|
2007-11-07 |
2011-10-27 |
Paul Michael Watt |
Antimicrobial compositions, formulations and uses thereof
|
US20100240057A1
(en)
|
2007-11-08 |
2010-09-23 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of chronic myeloid leukemia and acute lymphoblastic leukemia
|
PT2220116E
(pt)
|
2007-11-12 |
2012-12-07 |
Theraclone Sciences Inc |
Composições e métodos para a terapia e o diagnóstico da gripe
|
FR2925500B1
(fr)
|
2007-12-21 |
2011-05-06 |
Vincience |
Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
|
FR2925501B1
(fr)
|
2007-12-21 |
2012-12-14 |
Vincience |
Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
|
WO2009090651A2
(en)
|
2008-01-15 |
2009-07-23 |
Technion Research And Development Foundation Ltd. |
Major histocompatibility complex hla-b2705 ligands useful for therapy and diagnosis
|
EP2247606B1
(en)
|
2008-01-23 |
2019-08-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the treatment of viral infections
|
US11260133B2
(en)
|
2008-02-21 |
2022-03-01 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to peptides and proteins with C-terminal elements
|
US20090298707A1
(en)
|
2008-03-18 |
2009-12-03 |
The Regents Of The University Of California |
Sparse matrix system and method for identification of specific ligands or targets
|
WO2009146179A1
(en)
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
EP2113255A1
(en)
|
2008-05-02 |
2009-11-04 |
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. |
Cytotoxic immunoglobulin
|
US20090281038A1
(en)
|
2008-05-09 |
2009-11-12 |
University Of Kentucky Research Foundation |
Phylloplanins Inhibition of Microbial Growth on Organic Materials
|
KR20110016867A
(ko)
|
2008-05-16 |
2011-02-18 |
주식회사 프로셀제약 |
세포투과성 p27 재조합 단백질, 이를 코딩하는 폴리뉴클레오티드 및 이를 유효성분으로 함유하는 항암 조성물
|
CN102143971A
(zh)
|
2008-07-04 |
2011-08-03 |
巴斯夫植物科学有限公司 |
通过过表达编码tfl-1 样蛋白的多核苷酸而具有增强的产量相关性状的植物及其制备方法
|
DK2853545T3
(en)
|
2008-09-17 |
2016-08-29 |
Xencor Inc |
Antibody specific for IgE
|
JP5299956B2
(ja)
|
2008-09-29 |
2013-09-25 |
国立大学法人東北大学 |
質量分析装置を用いた代謝酵素群の一斉タンパク質定量に用いるペプチド
|
EP2337795A2
(en)
|
2008-10-01 |
2011-06-29 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
EA028336B1
(ru)
|
2009-03-05 |
2017-11-30 |
МЕДАРЕКС Л.Л.Си. |
Полностью человеческие антитела, специфические в отношении cadm1
|
CA2750836C
(en)
|
2009-04-09 |
2018-05-01 |
Daiichi Sankyo Company, Limited |
Anti-siglec-15 antibody
|
ES2566602T3
(es)
|
2010-04-09 |
2016-04-14 |
Aveo Pharmaceuticals, Inc. |
Anticuerpos anti-ErbB3
|
WO2012045481A2
(en)
*
|
2010-10-05 |
2012-04-12 |
Daiichi Sankyo Company, Limited |
Antibody targeting osteoclast-related protein siglec-15
|
CA2868959A1
(en)
|
2012-03-30 |
2013-10-03 |
Daiichi Sankyo Company, Limited |
Cdr-modified anti-siglec-15 antibody
|
MX2015000863A
(es)
|
2012-07-19 |
2016-05-05 |
Alethia Biotherapeutics Inc |
Anticuerpos anti-siglec-15.
|